Cerebral Small Vessel Disease and Its Associations with Cognitive Impairment, Gait Disturbance, and Europsychiatric Symptoms: A Narrative Review.
Key claim: Cerebral small vessel disease serves as a shared microvascular substrate driving late-life cognitive decline, gait impairment, and neuropsychiatric symptoms through endothelial dysfunction and chronic hypoperfusion.
Abstract
Cerebral small vessel disease (CSVD) encompasses a heterogeneous group of pathological processes affecting the small arteries, arterioles, capillaries, and venules of the brain. Beyond its well-recognized role in lacunar stroke and intracerebral hemorrhage, CSVD is increasingly understood as a major contributor to cognitive decline, gait impairment, and mood disturbances in older adults. These non-stroke manifestations often coexist and share common pathophysiological substrates, including endothelial dysfunction, blood-brain barrier disruption, chronic hypoperfusion, neuroinflammation, oxidative stress, and disruption of structural and functional brain networks. This narrative review synthesizes current evidence on the epidemiology, neuroimaging markers, and pathophysiological mechanisms of CSVD, with particular attention to its associations with cognitive impairment (predominantly executive dysfunction and slowed processing speed), gait abnormalities (reduced walking speed, increased stride variability, and elevated fall risk), and europsychiatric symptoms (vascular depression, apathy, and anxiety). The interactive relationships among these clinical phenotypes and the amplifying effects of comorbidities such as diabetes are also discussed. Finally, we review existing intervention strategies, particularly blood pressure control, and highlight emerging therapeutic targets and unresolved questions that warrant further investigation.
Why this matters
Cerebral small vessel disease serves as a shared microvascular substrate driving late-life cognitive decline, gait impairment, and neuropsychiatric symptoms through endothelial dysfunction and chronic hypoperfusion.